Daniel J Safer

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Prolactin serum concentrations during aripiprazole treatment in youth
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Child Adolesc Psychopharmacol 23:282-9. 2013
  2. doi request reprint Age-grouped differences in bipolar mania
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Compr Psychiatry 53:1110-7. 2012
  3. ncbi request reprint A comparison of risperidone-induced weight gain across the age span
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Clin Psychopharmacol 24:429-36. 2004
  4. doi request reprint Mood swing and mood stabilizer: how specific are these terms?
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Bipolar Disord 12:685-90. 2010
  5. ncbi request reprint Concomitant psychotropic medication for youths
    Daniel J Safer
    Division of Child Psychiatry, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Am J Psychiatry 160:438-49. 2003
  6. ncbi request reprint Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?
    Daniel J Safer
    Johns Hopkins University School of Medicine, Departments of Psychiatry and Pediatrics, Baltimore, Maryland, USA
    Pediatrics 118:1248-51. 2006
  7. doi request reprint Age-grouped differences in adverse drug events from psychotropic medication
    Daniel J Safer
    Department of Psychiatry, Johns Hopkins Institutions, Baltimore, Maryland, USA
    J Child Adolesc Psychopharmacol 21:299-309. 2011
  8. ncbi request reprint Do antidepressants reduce suicide rates?
    D J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Public Health 121:274-7. 2007
  9. ncbi request reprint Pemoline hepatotoxicity and postmarketing surveillance
    D J Safer
    Division of Child Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Am Acad Child Adolesc Psychiatry 40:622-9. 2001
  10. ncbi request reprint Stimulant treatment in Maryland public schools
    D J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Pediatrics 106:533-9. 2000

Detail Information

Publications29

  1. pmc Prolactin serum concentrations during aripiprazole treatment in youth
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Child Adolesc Psychopharmacol 23:282-9. 2013
    ..This study aimed to: document the extent of the reduction of serum prolactin (PRL) levels induced by aripiprazole (ARI) treatment in children and adolescents, compare this effect by age group, and shed light on this phenomenon...
  2. doi request reprint Age-grouped differences in bipolar mania
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Compr Psychiatry 53:1110-7. 2012
    ..This review of published studies compares scores on individual items of mania rating scales that systematically recorded symptom severity in persons diagnosed with bipolar disorder to identify age-grouped differences...
  3. ncbi request reprint A comparison of risperidone-induced weight gain across the age span
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Clin Psychopharmacol 24:429-36. 2004
    ..Available data thus suggest that across the age span, youths are the most sensitive to weight gain induced by a commonly prescribed second-generation neuroleptic...
  4. doi request reprint Mood swing and mood stabilizer: how specific are these terms?
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Bipolar Disord 12:685-90. 2010
    ..Within a short period of time thereafter, mood swing and mood stabilizer became very commonly used terms in psychiatry with bipolar implications...
  5. ncbi request reprint Concomitant psychotropic medication for youths
    Daniel J Safer
    Division of Child Psychiatry, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Am J Psychiatry 160:438-49. 2003
    ..This study reviewed the clinical research and practice literature relating to the prevalence and patterns of concomitant psychotropic medication given to youths with emotional and behavioral disorders...
  6. ncbi request reprint Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?
    Daniel J Safer
    Johns Hopkins University School of Medicine, Departments of Psychiatry and Pediatrics, Baltimore, Maryland, USA
    Pediatrics 118:1248-51. 2006
  7. doi request reprint Age-grouped differences in adverse drug events from psychotropic medication
    Daniel J Safer
    Department of Psychiatry, Johns Hopkins Institutions, Baltimore, Maryland, USA
    J Child Adolesc Psychopharmacol 21:299-309. 2011
    ..This review aims to detail specific psychotropic medication treatment differences in adverse drug events (ADEs) between children, adolescents, and adults...
  8. ncbi request reprint Do antidepressants reduce suicide rates?
    D J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Public Health 121:274-7. 2007
    ..We conclude that available ecological evidence does not support an inverse temporal relationship between rates of completed suicide and SSRI utilization...
  9. ncbi request reprint Pemoline hepatotoxicity and postmarketing surveillance
    D J Safer
    Division of Child Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Am Acad Child Adolesc Psychiatry 40:622-9. 2001
    ..S. Food and Drug Administration (FDA) between 1975 and 1996 and to describe the medical community's lack of awareness of these reports...
  10. ncbi request reprint Stimulant treatment in Maryland public schools
    D J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Pediatrics 106:533-9. 2000
    ....
  11. ncbi request reprint Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents
    Daniel J Safer
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21218, USA
    J Child Adolesc Psychopharmacol 16:159-69. 2006
    ..The aim of this study was to report the frequency of common treatment-emergent adverse events (AEs) from selective serotonin reuptake inhibitors (SSRIs) in children, adolescents, and adults...
  12. doi request reprint Psychotropic medication patterns among youth in foster care
    Julie M Zito
    Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD 21201, USA
    Pediatrics 121:e157-63. 2008
    ..Systematic data on patterns of medication treatment, particularly concomitant drugs, for youth in foster care are limited...
  13. doi request reprint Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression
    Satish Valluri
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Med Care 48:947-54. 2010
    ..To assess the national impact of the March 2004 Food and Drug Administration (FDA) antidepressant suicidality warning on the outpatient treatment of new-onset depression in youth...
  14. ncbi request reprint Antidepressant prevalence for youths: a multi-national comparison
    Julie M Zito
    University of Maryland, Baltimore, MD 21201, USA
    Pharmacoepidemiol Drug Saf 15:793-8. 2006
    ..To compare antidepressant prevalence data in youths across three western European countries (Denmark, Germany, and the Netherlands) with US regional data in terms of age and gender and to show proportional subclass antidepressant (ATD) use...
  15. ncbi request reprint Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths
    Julie Magno Zito
    University of Maryland, Baltimore, 515 West Lombard Street, Baltimore, Maryland 21201, USA
    Psychiatr Serv 56:157-63. 2005
    ..This study sought to determine the degree to which Medicaid eligibility categories modify disparities between black and white youths in the prevalence of psychotropic medication...
  16. ncbi request reprint Psychotropic practice patterns for youth: a 10-year perspective
    Julie Magno Zito
    Department of Pharmacy Practice and Science, University of Maryland, 100 Greene St, Room 5 13, Baltimore, MD 21201, USA
    Arch Pediatr Adolesc Med 157:17-25. 2003
    ..To examine changes in the full spectrum of psychotropic medication treatment for youths from 1987 to 1996...
  17. ncbi request reprint Psychotherapeutic medication prevalence in Medicaid-insured preschoolers
    Julie M Zito
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    J Child Adolesc Psychopharmacol 17:195-203. 2007
    ..To update knowledge of the prevalence of the use of psychotherapeutic medications in preschoolers with Medicaid insurance as requested by the Best Pharmaceuticals for Children Act of 2002 (BPCA)...
  18. ncbi request reprint Multiple psychotropic medication use for youths: a two-state comparison
    Susan dosReis
    Johns Hopkins Medicine, Division of Child and Adolescent Psychiatry, Baltimore, MD 21287, USA
    J Child Adolesc Psychopharmacol 15:68-77. 2005
    ..The aim of this study was to compare multiple psychotropic use among youths enrolled in two U.S. mid-Atlantic state Medicaid and state Children's Health Insurance Programs (SCHIP)...
  19. ncbi request reprint Rising prevalence of antidepressants among US youths
    Julie Magno Zito
    School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Pediatrics 109:721-7. 2002
    ..To examine changes in antidepressant (ATD) prevalence and the sociodemographic and clinical correlates of ATD use among youths who are treated in community practice settings...
  20. ncbi request reprint Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths
    Daniel J Safer
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, USA
    Psychiatr Serv 55:1049-51. 2004
    ..These administrative differences may partly explain the comparatively higher rate of psychotropic use under the SCHIP...
  21. doi request reprint National trends in pediatric use of anticonvulsants
    Allen R Tran
    Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch St, Baltimore, MD 21201, USA
    Psychiatr Serv 63:1095-101. 2012
    ..This research study aimed to assess national trends in pediatric use of anticonvulsants for seizures and psychiatric disorders...
  22. ncbi request reprint Is there a connection between methylphenidate and cancer in youth?
    Julie Magno Zito
    University of Maryland, Pharmaceutical Health, 220 Arch St, Baltimore, Maryland, USA
    Pharmacoepidemiol Drug Saf 16:1273-4. 2007
  23. ncbi request reprint Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder
    Susan dosReis
    Division of Child and Adolescent Psychiatry, School of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    J Dev Behav Pediatr 24:155-62. 2003
    ..The findings highlight parental misconceptions and reservations about ADHD medication treatment that require clarification as to whether race/ethnicity, income, and social status influence their views and use of treatments...
  24. pmc Mental health services for youths in foster care and disabled youths
    S dosReis
    School of Pharmacy, University of Maryland, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD, USA
    Am J Public Health 91:1094-9. 2001
    ..This study assessed whether mental health services for youths differ with respect to medical assistance aid category...
  25. ncbi request reprint Design and reporting modifications in industry-sponsored comparative psychopharmacology trials
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, 7702 Dunmanway, Dundalk, MD 21222, USA
    J Nerv Ment Dis 190:583-92. 2002
    ....
  26. ncbi request reprint Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder
    J M Zito
    Department of Pharmacy Practice and Science, School of Pharmacy, University of Maryland, Baltimore, USA
    Arch Pediatr Adolesc Med 153:1257-63. 1999
    ....
  27. doi request reprint Number needed to harm: its limitations in psychotropic drug safety research
    Daniel J Safer
    Departments of Psychiatry and Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD and Pharmaceutical Health Services Research Department, University of Maryland, Baltimore
    J Nerv Ment Dis 201:714-8. 2013
    ..Postmarketing surveillance of community treatment populations using case-control methodology provides far more useful data on serious ADEs. ..
  28. doi request reprint Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade
    Julie Magno Zito
    Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD 21201, USA
    Psychiatr Serv 64:223-9. 2013
    ..This cross-sectional study evaluated the impact of Medicaid-eligibility category on the increased use of antipsychotic medication by Medicaid-insured youths across a decade...
  29. ncbi request reprint Anticonvulsant treatment for psychiatric and seizure indications among youths
    Julie Magno Zito
    Department of Pharmaceutical Health Services Research, University of Maryland in Baltimore, MD 21201, USA
    Psychiatr Serv 57:681-5. 2006
    ..This study compared the prevalence of anticonvulsant treatment for youths with a diagnosis of a psychiatric disorder to youths with a diagnosis of a seizure disorder...